Wang Plastic Surgery

You are here: Home News, Events & Specials News Move Over BOTOX®, XEOMIN® is a New Kid in Town

Move Over BOTOX®, XEOMIN® is a New Kid in Town

by Stewart P. Wang ,  Wednesday, 01 February 2012 13:31
01 Feb

In this article from Around Alhambra, Dr. Wang compares BOTOX with the new FDA-approved wrinkle reduction treatment, XEOMIN.

For years Botox has been the primary injectable medicine for wrinkle  reduction,  especially around  the  eyes  area. A  new product, Xeomin, just recently received  FDA  approval  for wrinkle reduction. It is entering the market to compete with Botox  in  this  highly  popular beauty treatment arena.

Xeomin offers similar benefits  as  Botox.  Recently we treated several patients with Xeomin in the same areas that they normally would have been injected with Botox. The early subjective  reaction  is  that  it took  a  little  longer  for  the Xeomin  to work but  that  the action of Xeomin appeared to be  a  little  stronger.  At the present time, the patients have only  been  injected  for  about eight weeks. We will follow their progress in  the next  few months  to  see  how  long  the Xeomin  lasts  compared  to Botox.

Botox is the brand name for botulinu toxin.  It has  been used extensively for the medical treatment of muscle spasms and spasticity. Botox Cosmetic was  introduced  in  the  late 1980s  and  has  been  used  by millions of patients worldwide for  the  cosmetic  treatment  of wrinkle  reduction.  In recent studies, 2.8 million people have received Botox on a yearly basis. Statistics show that men are increasingly following their female counterparts’ footsteps and getting Botox treatment. The injection process  is quite simple, and quick, aiding the rise in Botox’s popularity as people seek safe and simple solutions  to minimize wrinkles without  significant  risks  or downtime.

Typically, Botox takes about two to three days to start working and the full effect may not be seen until one to two weeks after injection. The duration of the effect can vary depending on the dose used, size, activity of the muscles treated, and individual sensitivity to the medication.  In general, we expect each  injection  session  to  last several months. Side effects are uncommon but not rare. Typically, minor bruising or temporary drooping of the affected area may be encountered.

Xeomin is presently offered in a few selected  offices. The manufacturer is offering an incentive program for patients who are willing to try the product, with  a mail-in  refund  of $50  per  treatment. We are to our patients.

Since Botox has  had  a longstanding history of safe and successful use, it remains to be seen whether Xeomin  can  be just as effective if not better.

Should you have any questions, please do not hesitate to call and speak to one of my staff. We will be happy to review the benefits and limitations of each treatment as well as  any other suitable alternatives. This can be done not only in English but in Spanish and Mandarin as well. Our office offers comprehensive treatment options to assist you in your pursuit of everlasting beauty.

 

Would you like to schedule an appointment, give us a call or send us an email

Privacy Policy  |  Related Resources  |  Sitemap   

Board certified plastic surgeon Dr. Stewart Wang specializes in Pasadena breast augmentation as well as breast enhancement, hair transplant, face lift, laser hair removal, eyelid surgery (blepharoplasty), nose surgery (rhinoplasty), abdominoplasty (tummy tuck) and breast lift. He has cosmetic surgery offices and med spas in Upland, Pasadena, Glendora and Santa Ana and serves Southern California including La Verne, San Dimas, Chino Hills, Diamond Bar, Yorba Linda, Riverside, Rancho Cucamonga, Brea, Fullerton, Orange, Tustin, and Irvine.

Locations

  • 76 North Hudson Avenue #113 Pasadena, CA 91101
  • (626) 796-6680
  • 510 North 13th Avenue #303 Upland, CA 91786
  • (909) 985-6030
  • 1345 S. Grand Ave. Glendora, CA 91740
  • (626) 509-5337
  • 817 West 17th Street Santa Ana, CA 92706
  • (626) 796-6680

Newsletter